Loading data for MDWD — first visit, this takes a few seconds.
MediWound Ltd. (MDWD)
NasdaqGM: MDWD
· 即時價格 · USD
13.14
+0.08 (0.61%)
收盤價： Sep 03, 2026, 4:18 PM
股價、關鍵數字和最新消息，都在這一頁。
MediWound Ltd.（MDWD）股價、分析與資料
無可用資料
| 買價 | 10.22 |
| 市值 | 170M |
| 營收 (ttm) | 11.9M |
| 淨利（ttm） | -20.2M |
| 0.16 | |
| -2.16 | |
| n/a | |
| -5.74 | |
| P/B (ttm) | 4.76 |
| P/S (ttm) | 14.31 |
| 財報日期 | Nov 19, 2026 |
| 賣價 | 18.25 |
| 成交量 | 28,922 |
| 20 日平均成交量 | 84,082 |
| 開盤價 | 13.10 |
| 前收盤價 | 13.06 |
| 當日區間 | 12.81 - 13.18 |
| 52 週範圍 | 12.52 - 20.30 |
| 分析師 | n/a |
| 目標價 | n/a |
| 股利 | n/a |
| 除息日 | n/a |
關於 MDWD
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. It also develops Esc...
完整的公司簡介財報驚奇
MediWound 已於 Aug 13, 2026 公布季度財報：
- 營收為 $1.48M 低於預期 $0, 年增 -62.71% 下滑.
- 每股盈餘為 -0.57 超出預期 0.20, 年增 53.66% 成長.
第 1 頁，共 2 頁